WHO ICTRP trial
A Study to Evaluate Efficacy of Selected Homoeopathic Medicines in Prevention of…
CTRI/2020/10/028280 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/10/028280 |
|---|---|
| Public title | A Study to Evaluate Efficacy of Selected Homoeopathic Medicines in Prevention of COVID-19 |
| Scientific title | A Pragmatic, Placebo-controlled, Parallel Groups, Randomised Clinical Trial to Assess the Efficacy of Homoeopathic Medicine(s) in the Prevention of COVID-19 in a High Risk / Exposed Population |
| Primary sponsor | Directorate of AYUSH Govt of NCT of Delhi |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Interventions | Intervention1: Homoeopathic Medicine: Subjects will receive either of the three medicines (Arsenic album 30, Camphora 1M, Bryonia alba 30) or placebo. Two doses each of 4 pills of size 30 to be administered daily for 7 days; thereafter two… |
| Registration date | Jul 10, 2020 |
| Target size | 18000 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: